TCH-019 Implementation of a Monitored Information System Protocol in Pharmaceutical Monitoring

Background Information and communication technologies increase efficiency and safety in health systems. The SiMON protocol (Monitored Information System), developed by the R&D department of hospital’s Computing Service, provides a tool for monitoring patients attending a particular consultation and is adaptable in line with the needs of each clinical service. Its main objective is to streamline care by automating patient information related to such consultation. Furthermore, it provides a record for future analysis of information collected, making it possible to export information, scorecards and predict comorbidities. Purpose To describe the implementation of SiMON in pharmaceutical monitoring of patients with viral diseases (HIV/HCV). Materials and Methods Review of antiretroviral technical datasheets, pegylated interferon, ribavirin and protease inhibitors (boceprevir/telaprevir) and of the necessary literature to collect criteria and general recommendations for treatment of these diseases, adverse drug effects, interactions between these drugs and others, and contraindications for use. Results In order to implement SiMON in the pharmaceutical monitoring of patients with HIV/HCV, the Pharmacy Service reviewed 15 datasheets of antiviral drugs. Usage alerts were established as well as recommendations for each drug that depend on patient data (83 alerts), prescribed dosage (34 alerts), laboratory test results (94 alerts) and interactions between different medicinal products (484 alerts). Each of these alerts can refer to a contraindication or usage precaution, with a possible recommendation to suspend treatment, adjust the dose or change the drug involved in the interaction for an alternative. We also collected 482 adverse drug effects that had to be structured in tree form so they could be encoded by the Computing Service. Conclusions The SiMON protocol, a tool that increases the efficiency of patient monitoring in a multidisciplinary way, makes it possible to record side effects and generate drug alerts and it may be possible to make additional use of the data stored. Collaboration between different services increases the performance of tools at our disposal. No conflict of interest.